26 results on '"Rubio‐Beltrán, Eloísa"'
Search Results
2. Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research
3. Potential Side Effects and Pregnancy
4. Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab
5. Sex Hormones and CGRP
6. Understanding CGRP and Cardiovascular Risk
7. Potential Side Effects and Pregnancy
8. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine
9. Sex Hormones and CGRP
10. Understanding CGRP and Cardiovascular Risk
11. Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
12. Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats
13. Trigeminovascular effects of propranolol in men and women, role for sex steroids
14. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats
15. Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America
16. Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman’s life: Implications for the efficacy and safety of novel antimigraine medications
17. Characterization of binding, functional activity, and contractile responses of the selective 5‐HT 1F receptor agonist lasmiditan
18. Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan.
19. Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries
20. Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery – potential antimigraine efficacy
21. Is selective 5-HT 1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?
22. Gender aspects of CGRP in migraine
23. Gender aspects of CGRP in migraine.
24. Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?
25. Hypothalamic paraventricular nucleus stimulation enhances c-Fos expression in spinal and supraspinal structures related to pain modulation
26. Sex differences in CGRP-induced vasodilation of human middle meningeal arteries but not human coronary arteries: implications for migraine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.